[1]
2026. TREATMENT OUTCOMES OF PACLITAXEL–CARBOPLATIN–BEVACIZUMAB FOR RECURRENT OR METASTATIC EPITHELIAL OVARIAN CANCER AT NGHE AN ONCOLOGY HOSPITAL. Vietnam Journal of Community Medicine. 67, Số CĐ12- Bệnh viện Ung bướu Nghệ An (Aug. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD12.6150.